Beranda › Hemofilia
Uji klinis Hemofilia yang merekrut di AS
28 studi untuk Hemofilia merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Indianapolis, IN8 studi
- Los Angeles, CA7 studi
- Cedar Rapids, IA6 studi
- Seattle, WA6 studi
- Philadelphia, PA5 studi
- Tampa, FL4 studi
- Atlanta, GA4 studi
- Dallas, TX4 studi
- Little Rock, AR4 studi
- Sacramento, CA4 studi
- Greenville, NC4 studi
- Orange, CA4 studi
- Kansas City, MO3 studi
- St. Louis, MO3 studi
- Chicago, IL3 studi
- Detroit, MI3 studi
- San Antonio, TX3 studi
- Boston, MA3 studi
- Cincinnati, OH3 studi
- San Francisco, CA3 studi
- Aurora, CO3 studi
- Harrisburg, PA3 studi
Berdasarkan negara bagian
- Arkansas4 studi
- California14 studi
- Colorado3 studi
- Florida6 studi
- Georgia4 studi
- Illinois4 studi
- Indiana8 studi
- Iowa6 studi
- Massachusetts3 studi
- Michigan5 studi
- Missouri5 studi
- New York4 studi
- North Carolina6 studi
- Ohio5 studi
- Pennsylvania6 studi
- Texas8 studi
- Washington6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Menerima pesertaStudi observasional
6 Months · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07692217A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Menerima pesertaFase 4
Usia 12 ke atas · Pria · Diperbarui 23 Sep 2026 · NCT06145373A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Menerima pesertaFase 3
Usia 1 hingga 17 · Pria · Diperbarui 23 Sep 2026 · NCT05611801A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07416526Treatment of Hemophilia A Patients With FVIII Inhibitors
Menerima pesertaStudi observasional
Semua usia · Pria · Diperbarui 23 Sep 2026 · NCT04023019A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Pria · Diperbarui 18 Sep 2026 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Menerima pesertaFase 1/2
Usia 2 hingga 59 · Pria · Diperbarui 11 Sep 2026 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07416604SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Menerima pesertaFase 3
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04563520Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Menerima pesertaFase 3
Usia 1 hingga 11 · Pria · Diperbarui 17 Agu 2026 · NCT07285460A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT06349473Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Menerima pesertaStudi observasional
Usia 6 hingga 19 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05022459Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Menerima pesertaFase 3
Usia 1 hingga 74 · Pria · Diperbarui 1 Jul 2026 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Menerima pesertaFase 1
Usia 12 hingga 74 · Pria · Diperbarui 3 Jun 2026 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT03695978Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 27 Mei 2026 · NCT05568719Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Menerima pesertaFase 4
Usia 12 ke atas · Wanita · Diperbarui 12 Mei 2026 · NCT05936580Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Menerima pesertaFase 4
Usia 12 ke atas · Pria · Diperbarui 12 Mei 2026 · NCT05935358ATHNdataset Registry
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Menerima pesertaFase 1
Usia 0 hingga 90 · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT05500807Hemophilia A Research Program
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT07414511SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Menerima pesertaFase 4
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 12 Jan 2026 · NCT04647227Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.